Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling
Yuwei Yang, Siqi Ouyang, Xueyu Hu, Mingyue Zheng, Hao Zhou, Lei Li

TL;DR
This paper introduces MolEdit3D, a 3D graph editing model for structure-based drug design that combines molecular generation with optimization, achieving state-of-the-art results in generating high-affinity ligands.
Contribution
It presents a novel 3D graph editing approach pre-trained on ligands and a target-guided self-learning strategy to enhance target-specific properties.
Findings
MolEdit3D outperforms existing methods on key metrics.
The model effectively captures target-dependent and independent properties.
Pre-training on abundant ligands improves generation quality.
Abstract
Structure-based drug design aims at generating high affinity ligands with prior knowledge of 3D target structures. Existing methods either use conditional generative model to learn the distribution of 3D ligands given target binding sites, or iteratively modify molecules to optimize a structure-based activity estimator. The former is highly constrained by data quantity and quality, which leaves optimization-based approaches more promising in practical scenario. However, existing optimization-based approaches choose to edit molecules in 2D space, and use molecular docking to estimate the activity using docking predicted 3D target-ligand complexes. The misalignment between the action space and the objective hinders the performance of these models, especially for those employ deep learning for acceleration. In this work, we propose MolEdit3D to combine 3D molecular generation with…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChemical Synthesis and Analysis · Computational Drug Discovery Methods · Monoclonal and Polyclonal Antibodies Research
MethodsSelf-Learning
